Jingyi is a partner of Cooley’s fund formation practice. Her practice focuses on the formation and representation of private investment funds both in the United States and internationally. In particular, Jingyi specializes in representing fund managers investing in China in connection with the formation of their USD-dominated funds, including venture capital funds, private equity funds and project funds, as well as upper-tier arrangements, carried interest plans and various governance matters. Jingyi also represents institutional investors (including sovereign wealth funds and funds of funds) and other investors in connection with investments in private funds.

Jingyi has been recognized as a "Next Generation Partner" for Investment Funds practice in China by the Legal 500 Asia Pacific from 2022 to 2025. She is also recognized as one of the “2024 ALB China Top 15 Rising Lawyers” and the “2022 Rising Stars” by China Business Law Journal. 

1. 作为毕马威中国金融行业主管合伙人、资产管理行业主管合伙人和私募股权行业联席主管合伙人，吴先生为私募股权基金、主权基金及国企客户提供过众多里程碑项目的尽调服务。
2. Louis与其客户就毕马威如何在提供更严谨有针对性的尽调工作及价值创造保持持续动态交流，并持续关注科技、关税和ESG等关键因素的影响，以帮助我们的客户在投资环境得到更多的保护和增值
3. 同时，Louis在2006年赴华任职之前，曾就职于毕马威新加坡及伦敦分公司，对经济环境及地缘政治对金融行业的影响、全球PE行业动态、及中外金融环境具备一定专业积累。在就职专业领域广泛联络相关国内外交易咨询行业专业人士、客户、同事及潜在投资者，对中外PE行业交流具有积极的推动作用

Tim Burroughs is managing editor of Asian Venture Capital Journal, having joined the publication in May 2011. He is responsible for all editorial content put out under the AVCJ brand, including Asian Venture Capital Journal, AVCJtv, AVCJ Awards and AVCJ.com. Tim previously spent five years at China Economic Review, serving as editor-in-chief and then editorial director. Located in Greater China since 2003, during which time he has lived in Beijing, Qingdao and Hong Kong, Tim has been a China-based contributor for publications including The Sunday Times, Sunday Telegraph, BBC and China Daily. Prior to moving to China, he trained and worked as a journalist in the UK. He was honored at the Society of Publishers in Asia awards in 2007, 2008 and 2010, and at the State Street Institutional Press Awards - Asia in 2012.

Yiqing Wang is Managing Editor of Mergermarket’s Asia-Pacific M&A and ECM editorial team, which specializes in breaking news on private and public M&A transactions and delivering forward-looking intelligence on corporate strategy. Yiqing spearheads the editorial strategy and oversees day-to-day operations, to deliver timely, actionable insights and analysis to help clients make better deal-making and investment decisions. Additionally, she frequently moderates panels and chairs conferences at ION Analytics events, bringing industry insights to the forefront.

She has been an investigative M&A reporter and editor since 2009, writing news ranging from healthcare, renewable energy and financial service, etc.

Yiqing achieved her master's degree of multilingual multicultural studies from New York University.

Rebecca Xu is a Co-Founder and Managing Director of Asia Alternatives. Ms. Xu splits her time between Asia Alternatives’ Beijing, Shanghai and Hong Kong offices. Ms. Xu is on the Firm’s Investment Committee and co-leads Asia Alternatives’ investments in growth and venture capital funds, focusing most of her time on Asia Alternatives’ China investments. 

Prior to starting Asia Alternatives, Ms. Xu was a Senior Investment Officer at the Funds Group of the International Finance Corporation (“IFC”), the private sector investment arm of the World Bank Group. There, she had the primary responsibility of leading IFC’s fund investing and portfolio supervision in Asia for over six years. Previously, Ms. Xu also worked at McKinsey & Co, Inc. (Washington D.C.) and HSBC (Hong Kong). 

Ms. Xu received an M.B.A. from Harvard Business School and holds a Bachelor’s degree in International Relations from the Foreign Affairs College in Beijing, China. Ms. Xu is fluent in Mandarin Chinese. 

Ms. Xu currently serves on the Advisory Boards for a number of Asia Alternatives’ China and India private equity funds. In addition, she serves as the Chairwoman of the Hong Kong Venture Capital and Private Equity Association (HKVCA) and on the Board of the Chun Hui Bo’ai Children’s Foundation.

Michael Chen is a managing director and member of Investment Committee at Centurium Capital. Mr. Chen also serves as a Director of Luckin Coffee (OTC: LKNCY) and Co-chairman of the company’s Sustainable Development Committee, and Co-chairman of ANE Inc. (HKSE: 9956) and Chairman of the company’s ESG Committee. Mr. Chen is an experienced private equity investor in China with a proven track record of successful investments. Prior to joining Centurium, he led Warburg Pincus’ consumer and services investments in China.  Prior to joining Warburg Pincus in 2011, Mr. Chen was a vice president in Crescent Point, a Pan-Asia growth capital fund. Before Crescent, Mr. Chen was an associate in the investment banking division of Morgan Stanley in Hong Kong and a consultant with Accenture in China. He received a B.A. of economics from Fudan University and an M.B.A. from INSEAD.

Zhan is an Investment Principal and General Manager of Coller’s Beijing office. He is responsible for origination and execution, and is based in the firm’s Hong Kong and Beijing offices.

Prior to joining Coller Capital in 2016, Zhan was a Director at BlackRock Private Equity Partners. Previously, he worked at Swiss Re Private Equity Partners and Adveq Management in Zurich, Beijing and Hong Kong.

Zhan has a BEng in Environmental Engineering from Tianjin University, an MSc in Environmental Science from Nanyang Technological University and an MBA from INSEAD. Zhan is a CFA Charterholder.

Leigh joined Han Kun Law Offices in 2012 and is a partner in the firm's Investment Fund Team. Based in Shanghai, Leigh frequently travels to the Greater Bay Area and Singapore to manage client relationships in those regions.  She focuses her practice on investment fund formation and operation, asset management, and foreign direct investment, with a particular emphasis on private equity and venture capital. Leigh possesses extensive expertise in RMB and US dollar fund formation, as well as significant experience in cross-border investment matters, including QFLP, QDLP/QDIE, QFII, and QDII. 

Educational background

Sun Yat-sen University, LL.B.

Columbia Law School, LL.M. (with honors)

Seoul National University, LL.M.

INSEAD, Global Executive MBA (Class of 2025)

Alex Shum is a Business Unit Partner of TPG NewQuest, based in Hong Kong. Alex joined TPG NewQuest in 2011 and is responsible for the sourcing, execution and portfolio management of investments across the Greater China and North Asia regions. Alex has more than 15 years of experience in finance across investments, capital raising, M&A and corporate advisory. Prior to joining TPG NewQuest, Alex was an Associate at Credit Suisse’s Investment Bank based in Hong Kong, where he worked in the corporate finance and equity capital markets departments. Alex received his undergraduate degree in Economics from Duke University. He is fluent in English, Mandarin and Cantonese.

Mr. Lai is responsible for originating, evaluating, negotiating, and monitoring of private equity investments in Asia. He joined Manulife in 2020. Prior to that, he was a senior member of the private equity group at Full Vision Capital, where he was responsible for private equity investments globally and driving strategic and operational changes at portfolio companies. He also worked in the the private equity group at China Merchants Securities. Mr. Lai hold a bachelor’s degree in Economics from University College London and a Graduate Diploma in Law from BPP Law School.

Mr. Chen joined Bain Capital in 2005. He is a Partner in the Technology, Media & Telecommunications Vertical and a founding member of the Asian Pacific Private Equity team. Mr. Chen has worked in both the Boston and Hong Kong offices and focuses on growth capital and buyouts in the technology, media and business services sectors.  

Prior to joining Bain Capital Private Equity, Mr. Chen was a consultant with Bain & Company in Boston.

Mr. Huang is Head of Cross-Border Investment / M&A and Co-Head of Global Consumer at FountainVest Partners. He joined FountainVest in 2017. 

Mr. Huang sits on the boards of Amer Sports, Ziwi, Windrose Technology, and CFB Group. He previously sat on boards of Precor, Suunto and Trendy International. Prior to joining FountainVest, Mr. Huang spent 13 years with Goldman Sachs based in Hong Kong and New York, including as a Managing Director in the Mergers & Acquisitions Group and Head of China M&A. 

Mr. Huang holds an MBA in Finance from the Wharton School and a Bachelor of Arts in Economics and Political Science from Columbia University.

Maryann Tseng is Head of International Capital Markets, and Senior Managing Director of Strategic Investment Department at SenseTime Inc. 

SenseTime Inc is a Hong Kong Stock Exchange listed under ticker 0020.HK, with market capitalization of US$8.5bn artificial intelligence software services company. 

Prior to joining SenseTime Inc, Maryann was a highly recognized global markets and capital markets investment banker in Asia, mostly with Morgan Stanley; often highly ranked by Institutional Investor and Asia Money. 

Maryann holds adjunct associate professorship at Hong Kong PolyTech University; sits on the corporate advisory board of HKUST MSc Business Analytics program. She is a CIMA CGMA fellow; received Executive Education from Harvard Business School and Stanford University Business School and Law School. 

She now is based in Hong Kong, but travel frequently to key markets and countries globally for investors engagements, business commercialization and developments.

Ian Goh is a seasoned investor in the technology space with over 18 years of experience. He is the Founding Partner at 01VC, an early-stage venture firm focused on cross-border, supply chain, and deep tech investments. Ian has been an early investor in and board member of some of the most innovative companies in recent years, including Lalamove, XTransfer, and Hai Robotics. He also participated in the early investment in Baidu, one of China’s most iconic internet companies.

He has served on the boards of several public and acquired companies, such as Zhaogang.com (HKSE: 6676.HK), 7gege (acquired by La Chapelle, HKSE: 06116.HK), IN (NEEQ: 836484), Cgen Media (acquired by Nasdaq-listed Focus Media), Kanghui (acquired by Medtronic, NYSE: MDT), Madhouse.cn (acquired by BlueFocus, SZ: 300058), and A8.com (HKSE: 0800.HK).

Prior to founding 01VC, Ian was a Partner at Matrix Partners China, focusing on consumer internet and transaction platforms. He began his venture career in 2004 at TDF Capital, which later merged into Kleiner Perkins Caufield & Byers China, where he also served as Partner. Ian first came to China in 2001 to join Lycos Asia, one of the early internet pioneers, where he held corporate and business development roles.

He also played a strategic role in helping Kuadi Dache acquire its competitor Dahuangfeng, and introduced GrabTaxi to Didi Chuxing at a formative stage.

Born in Singapore and later educated in Australia, Ian holds a Bachelor of Commerce from Murdoch University. He is both a CFA charterholder and a qualified Chartered Accountant.

Boyu Hu is the founder of XVC, a 2-billion USD research-driven venture capital fund. According to Preqin's latest league table, XVC II was ranked #1 best performing VC fund globally of the 2019 vintage in the 250-499 million category. 

Boyu excels at singling out 'big ideas' at early-stage, and the market value of his portfolio companies, which includes Kuaishou, Weee!, Hetao coding, Chagee, etc., reached over 50 billion USD. 

Before becoming an investor, Boyu had nearly 10 years of entrepreneurial experience. He co-founded China’s largest credit risk management software company, Amarsoft (SHE:300380).

Sheng Liu is Head of Partners Group's China office and part of the Private Equity Health and Life business unit, based in Singapore. He is a member of the Health and Life Vertical Investment Committee as well as a member of the Board of Directors of the firm's portfolio companies Apex Logistics, Green Tea restaurant and Aiyingshi. He has been with Partners Group since 2013 and has 21 years of industry experience. Prior to joining Partners Group, he worked at Cathay Capital Private Equity as Investment Director in charge of both investment and value creation, and before that at KPMG. He holds a bachelor’s degree in finance from the Shanghai University of Finance and Economics, China.

Helen Wong is a Managing Partner at AC Ventures (ACV), an early-stage, Indonesia- focused technology venture capital fund. ACV manages five funds with an AUM of over US$500M and a portfolio of more than 120 businesses invested in the past eight years. The firm has led investments into Stockbit, Xendit, Shipper, Carsome and more.   

Forbes magazine ranked her among China’s “Top 25 female VCs” and “Top 100 investors”. Forbes also ranked her as one of three Singaporeans among the Top “50 over 50” in Asia Pacific in 2024. Helen is a venture capitalist with a strong track record (over 20 years of experience), as she was part of the founding team at GGV Capital, and served as a Partner at Qiming Ventures.   

Helen started her career in Silicon Valley/US, then moved to China, and now covers Southeast Asia. She led investments in Akulaku (a fintech unicorn) and Simplus in SE Asia, and has served the boards of highprofile Chinese internet companies. She has had 10 exits (7 IPOs and 3 M&As) among her portfolio companies including Tudou and QuantaSing on NASDAQ, Buchang on the Shanghai stock exchange, and Mobike (acquired by Meituan). 

Helen graduated with a B.A. degree from Oxford University and a M.B.A. from INSEAD. She also has an E.M.B.A. degree from Cheung Kong Graduate School of Business in China. She is a Kauffman Fellow, and also participated in the China European International Business School (“CEIBS”) venture capital program.   

Mr. Fu oversees the firm’s overall strategy, talent development and is responsible for maintaining the firm’s long-term partnerships with global investors. He has driven successful incubation and buyout strategies, shaping the firm’s differentiated investment approach. Under his leadership, CBC Group was recognized by PEI in 2024 as the #1 private equity firm in Singapore and Asia’s largest healthcare-focused firm, earning this title for the third consecutive year, with the Group’s AUM having grown from US$180 million in 2014 to US$10.5 billion today. 

He initiated and led investment transactions including Everest Medicines (HKEX 1952.HK), Hugel Inc. (KOSDAQ:145020), ENSEM Therapeutics (Boston, US) and I-Mab Biopharma (NASDAQ: IMAB), while also being instrumental in incubating several biotech and pharmaceutical companies. He serves as Chairman of the Board for Everest Medicines and I-MAB Biopharma respectively. 

Prior to founding CBC Group in 2014, he was formerly the General Manager of the investment department at a wholly owned subsidiary of Far East Horizon Limited (HKEX:3360). He has also worked for Standard Chartered Bank (China), Macquarie Capital (Singapore) and Temasek Holdings. 

Fu Wei graduated from Singapore’s Nanyang Technological University with a first-class honors degree in Electrical Engineering and a minor in Business Administration. He is a scholar of Singapore's Ministry of Education and a member of the prestigious Young President’s Organization.

Chang Liu (Chinese) is an Executive Director at LGT Investment Consulting (Beijing) Ltd., People's Republic of China. As part of the Asia private equity team, he is responsible for origination, due diligence and monitoring of private equity investments in Asia. He also leads the firm’s local business development efforts in mainland China. 

Prior to joining the firm in 2019, he was a senior associate at HarbourVest Partners in Beijing, focused on primary investments in the region. 

Mr. Liu holds a Bachelor's degree in Mathematics and Economics from Brandeis University. He is fluent in English and Mandarin.

Dr. Amit Kakar joined Novo Holdings Asia in August 2020 as Head of Asia to lead investments and partnerships across the region, focusing primarily on the markets in China, Southeast Asia and India. 

Dr. Kakar has more than 25 years of healthcare experience with several senior management roles across the globe and having worked in India, China, Singapore, Denmark and the USA. His previous roles include Head of M&A and Business Development at Everlife Asia, Head of Healthcare Investments for Asia with the Avenue Capital Group, and various senior leadership positions with GE Healthcare. 

Dr. Kakar is a Medical Doctor with a postgraduate degree in Radiation and Nuclear Medicine from Tata Memorial Hospital and Cancer Centre in Mumbai, India.

Frankie Fang is a founding managing partner of Starquest Capital, a private equity firm in China that focuses on Technology, Consumer and Healthcare. Mr. Fang lead the firm’s FoF investment as well as ESG implementation，through which Starquest Capital became the first RMB FoF in China that joined United Nations-supported Principles for Responsible Investment (UNPRI) in 2018 and the first Asian firm that won the UNPRI Awards 2019 “Emerging Markets Initiative of the Year.” In 2025, Mr. Fang was appointed as a Listing Committee member of the Stock Exchange of Hong Kong Limited (the Exchange) and became the first member from the FoF industry, pioneering a new path for the industry.

Prior to founding Starquest Capital in 2017, Mr. Fang served as head of LGT Capital Partners in China for 12 years. LGT is privately owned by the Princely Family of Liechtenstein with over USD 100 billion in assets under management. During his career, Mr. Fang has invested over $3 billion in the Chinese private equity market and led investments in a number of PE/VC funds by CITIC Capital, Hongshan, Legend Capital, Primavera Capital, Source Code Capital and Gaorong Ventures, etc. Mr. Fang also serves on advisory committees of over 20 funds in China. 

Mr. Fang has been actively involved in public service. In education field, Mr. Fang is a career mentor for Master of Finance Program at Tsinghua University School of Economics and Management, an industry advisor at China Europe International Business School (CEIBS) Entrepreneur Camp, a founder and donor of Shanghai Jiao Tong University Zheng Yang Scholarship as well as INSEAD Frankie Fang Scholarship. In social service field, Mr. Fang is a FoF committee member at Asset Management Association of China, a judge in venture capital field for Forbes China 2020 "30 Under 30", a council member of Future Forum Youth Council, which established the Future Science Prize hailed as the Chinese Nobel Prize, and a donor of Teach in China, which is an educational non-profit project.

Mr. Fang received a BA in Finance and Accounting from Antai College of Economics and Management, Shanghai Jiao Tong University in 2000, a MBA from INSEAD Business School in 2006, and an EMBA from Tsinghua University People’s Bank of China School of Finance in 2018. Mr. Fang holds a Chinese CPA qualification. Mr. Fang’s native language is Mandarin Chinese and he is fluent in English, French and Cantonese and conversational proficient in Japanese.

Ms. Ye has 10-year experience in Chinese PE/VC industry. She joined NIO Capital in 2017 with her responsibilities split across investment and fundraising team. On investment side, she oversees the general exit strategy across the portfolio, acts as the deal leader of several portfolio companies in post-investment management, and selectively participates in live deals. On fundraising side, she serves as the key contact to communicate with global LPs, including sovereign wealth funds, MNCs, financial institutions, throughout the due diligence and post-investment process. 

Prior to NIO Capital, Ms. Ye has worked for Hony Capital, a Chinese leading private equity firm. Ms. Ye holds a Bachelor’s degree from Fudan University with a major in International Finance and pursued her Master’s degree in Mathematical Finance at Boston University. 

Jason has over 18 years of experience in private equity, fund management, and investment banking. He was most recent with GLP Capital Partners, a global alternative asset manager with approximately US$125 billion in assets under management focusing on real assets and private equity, where he led investments in Greater China and Southeast Asia, in addition to overseeing and managing GLP’s investment in China Merchants Capital, one of China’s largest private equity investment platforms with US$47 billion in assets under management. Previously he was the Head of PIPE Investments at China Everbright Limited, a Chinese private equity and asset management platform, where he managed principal and third-party capital and invested in pre-IPO and late-stage Chinese companies. Before that, he was the Head of Direct Investment and a Managing Director at China Huarong Asset Management where he managed a US$1 billion portfolio of structured credit and mezzanine debt of Chinese companies. 

Before entering the private equity industry, Jason spent close to a decade as an investment banker at Citi and Standard Chartered Bank where he was responsible for advising and executing capital markets transactions and M&A for Chinese and Hong Kong corporates and global private equity funds, completing approximately US$5 billion of M&A transactions and US$10 billion of capital markets deals. 

Jason graduated cum laude from Columbia University with a B.S. in Industrial Engineering Operations Research and Economics.

Mr. Zheng joined Investcorp in January 2020 and is the Deputy Head of the Emerging Markets Group covering the GCC, Southeast Asia and Greater China. Notable investments under his tenure include VizBrands cereals, Lu Daopei blood oncology, Linkedcare dental SaaS and Jianuo high-end manufacturing, among others.

Previously, Mr. Zheng was with one of the leading German private equity firms Triton in Frankfurt, and the U.S. PE firm Hicks Muse Tate & Furst in Dallas, conducting control buyouts in Europe and North America in the business services, industrial and consumer sectors. Mr. Zheng started his career in investment banking at Salomon Smith Barney in New York and holds a Bachelor of Science degree from Boston College, as well as an Executive Diploma in Industry & Finance from Tsinghua University – Wudaokou.

Andrew Li joined Advent in 2012 and is a Managing Director in Shanghai. He advises on investments in the consumer, healthcare, and industrial sectors. Andrew has advised on 16 investments during his career, nine while at Advent. 

Prior to joining Advent, Andrew worked at Warburg Pincus, Solera Capital, and Credit Suisse throughout China and the US, where he focused on the energy, healthcare, industrial, and retail and consumer sectors. 

Andrew holds a BA from Middlebury College and an MBA from Harvard Business School.

Dr. LI Yao currently is the Chief Investment Officer for East Asia and Pacific Department of IFC, World Bank Group, based in Hong Kong. As the regional Climate Business Anchor and the regional South-South Business Anchor, he focuses on promoting Climate investment, South-South Outbound Investment, and Impact investment in the region. During his professional career before IFC, He took several top managerial roles with China Stated owned large sized financial institutions. Dr. LI also was with DRC of China State Council as the policy researcher on China opening policies in early 1990’s. 

Dr. LI holds PhD degree in Economics. His academic interests include the Global Sustainable Growth, the Transition Economics for Developing Countries.

Ling Yang is China Editor for Mergermarket, a global news intelligence service for advisors, private equity firms and corporates. She heads a team of dedicated specialists across China to cover corporate growth strategies, M&A deals, PE buyouts, cross-border M&A intelligence, as well as data-backed analysis and trend pieces.

Ling has been an investigative M&A reporter for 12 years with a special focus on private equity coverage. She was the head of consumer and retail coverage for APAC with Mergermarket. She joined Mergermarket in Hong Kong in 2011 before moving to Shanghai in 2016.

Ms. YARONG LA has 19 years of experience in finance and a 3-year entrepreneurial background. Since joining ORIZA FOFs in 2021, she has been primarily responsible for external partnerships, fundraising, investor relations, and public relations. 

Ms. LA has led her team in expanding and onboarding institutional investors, including financial institutions and state-owned capital, systematically establishing a professional fundraising framework. She has driven the structural transformation and upgrade of ORIZA FOFs’ LP base, building a top-tier institutional investor network in the market. Innovatively fostering collaborations with various institutional investors, she has spearheaded the design and execution of diverse partnership models— from fund structuring to investment strategy—playing a pivotal role in diversifying ORIZA FOFs’ asset classes and pioneering new cooperation approaches. Additionally, she has refined the LP service system and public relations framework, delivering comprehensive and precise pre- and postinvestment services to LPs. 

Ms. LA has been recognized as the Top 10 Most Popular IR Professionals, Top 20 Women in China’s Institutional LP Sector, and Top 20 Influential “Her Power” Figures in the industry. She previously served as a fundraising partner at a leading domestic wealth management firm, where she honed her expertise in fund financing, operations, and management, amassing extensive experience and resources

David Wong is a partner and Co-Head of Private Equity of PAG. He is responsible for supervising the operations and management of the Private Equity strategy. He is a member of the firm’s Management Committee.  Prior to joining PAG, Mr. Wong was a vice president at TPG Capital (formerly known as Newbridge Capital). He worked in the investment banking division of Morgan Stanley before that.

Mr. Wong received bachelor’s degrees in business administration and Asian studies from the University of California, Berkeley.

David Selvia is a Partner at The Cathay Capital Group (CCG), a multi-bb series of China-focused growth equity funds. From the early 90s Cathay’s funds have led investments into 50+ businesses with exits by way of MNC trade sales, and A Share, HKSE, NYSE & Nasdaq IPOs.

 David has 25+ years of investment experience in Asia. From 2000-2004 David led M&A/BD for various General Electric industrial business units, before then spearheading GE Capital’s China market entry. During his time at GE David was involved in dozens of new investments, JVs, partnerships as well as distressed workouts. Joining Cathay in 2006 in Hong Kong David went on to establish CCG’s Shanghai office before relocating to lead its Beijing operations. Currently David is responsible for new investments as well as cross-border initiatives.

 David holds a BA from Boston University, an MBA from UPenn’s Wharton School and an MA from UPenn’s Lauder Institute. He has served on dozens of boards, both public and private. David is based in Shanghai, and speaks Mandarin.

Perris Lee is the Asia ECM Editorial and Insights Director for ION Analytics. He looks after potential and live IPO, follow-on, and equity-linked bond deals, as well as producing the data-driven, forward-looking column “ECM Explorer APAC.”

Perris joined ION Analytics/Acuris in 2011 as the Taiwan correspondent for Dealreporter, covering both ECM and M&A matters. Soon after becoming a well-versed Taiwan-subject expert catering primarily to global hedge funds and proprietary desks, Perris expanded his mandate to include Asia convertible bonds in 2014 and further to Asia ECM in 2015. He was promoted to his current role in 2021.

Prior to joining ION Analytics, Perris spent nine years covering the Asian financial markets for Dow Jones Newswires and Bloomberg.

Charles joined CDH in 2018 and leads an investment team focused on Advanced Manufacturing & Technology. He is now a member of investment committee of CDH Private Equity. Prior to joining CDH, Charles was a Founding Partner with KYI Capital , a private equity firm focusing on core technology investments, and a Managing Partner with Beijing Semi Fund, a private equity firm focusing on semiconductor investments. Prior to that, Charles was a Director with CVCi and a Senior Engagement Manager with McKinsey & Company. He received his M.B.A. from IMD Business School in Switzerland and his B.E. in Electrical Engineering & Computer Science from Shanghai Jiaotong University.

Vice President of Shenzhen Capital Group, member of the Investment Committee. His responsibilities include leading departments that handle fundraising, project investment and post-investment services. He has extensive experience in investment and financing, as well as corporate management. He has management experience in government FoFs with AUM exceeding 100bn RMB.